Astellas Pharma Inc.

Astellas Pharma Inc. is a declared insider at 3 companies; the most frequent names are OSI Pharmaceuticals Inc, Kyntra Bio, Inc. and Sucampo Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 7 August 2007 to 19 November 2014.

On the market, this insider has only ever bought: 2 purchases, €363.3M in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The newest entry dates from 19 November 2014: a transaction, in Kyntra Bio, Inc. The last insider purchase was made public on 9 June 2010, 5,981 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.